A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Tasimelteon (Primary)
- Indications Circadian rhythm sleep disorders; Jet lag
- Focus Proof of concept; Therapeutic Use
- Sponsors Vanda Pharmaceuticals
- 14 Feb 2018 According to a Vanda Pharmaceuticals media release, results from this trial is expected in the first quarter of 2018.
- 14 Feb 2018 Status changed from recruiting to active, no longer recruiting, according to a Vanda Pharmaceuticals media release.
- 07 Nov 2017 According to a Vanda Pharmaceuticals media release, results from this trial are expected in the fourth quarter of 2017.